(AMBX:Consolidated Issue Listed on NASDAQ Global Select )
Kevin Johnson Ph.D.
Scientific Advisor, Ambrx, Inc.
|Age||Total Calculated Compensation||This person is connected to 12 board members in 4 different organizations across 9 different industries.|
See Board Relationships
Mr. Kevin Johnson serves as a Partner in the Life Sciences team at Index Ventures. He focuses on drug discovery, drug development, and enabling platforms. He serves as an Scientific Advisor of Ambrx, Inc. He is a General Partner in Ash Biotech Consulting. He served as Chief Technology Officer of Oxford GlycoSciences Plc. He served as Chief Technology Officer - Exploitation And Development of MedImmune Limited since 2000. He served as the Chief Executive Officer at PanGenetics. ...
10975 North Torrey Pines RoadPhone: 858-875-2400
La Jolla, California 92037
Board Members Memberships*
Former Chief Technology Officer - Exploitation And Development and Director
University of Cambridge
University of Edinburgh in Scotland
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|